51 related articles for article (PubMed ID: 24220314)
1. Criteria for arrhythmogenicity in genetically-modified Langendorff-perfused murine hearts modelling the congenital long QT syndrome type 3 and the Brugada syndrome.
Sabir IN; Li LM; Jones VJ; Goddard CA; Grace AA; Huang CL
Pflugers Arch; 2008 Jan; 455(4):637-51. PubMed ID: 17805561
[TBL] [Abstract][Full Text] [Related]
2. Ventricular arrhythmogenesis following slowed conduction in heptanol-treated, Langendorff-perfused mouse hearts.
Tse G; Hothi SS; Grace AA; Huang CL
J Physiol Sci; 2012 Mar; 62(2):79-92. PubMed ID: 22219003
[TBL] [Abstract][Full Text] [Related]
3. Indications for mexiletine in the new ESC guidelines and beyond.
Vamos M; Zsigmond EJ; Hohnloser SH
Expert Opin Pharmacother; 2023; 24(12):1403-1407. PubMed ID: 37306465
[TBL] [Abstract][Full Text] [Related]
4. The novel late Na
Rajamani S; Liu G; El-Bizri N; Guo D; Li C; Chen XL; Kahlig KM; Mollova N; Elzein E; Zablocki J; Belardinelli L
Br J Pharmacol; 2016 Nov; 173(21):3088-3098. PubMed ID: 27449698
[TBL] [Abstract][Full Text] [Related]
5. Human ex-vivo action potential model for pro-arrhythmia risk assessment.
Page G; Ratchada P; Miron Y; Steiner G; Ghetti A; Miller PE; Reynolds JA; Wang K; Greiter-Wilke A; Polonchuk L; Traebert M; Gintant GA; Abi-Gerges N
J Pharmacol Toxicol Methods; 2016; 81():183-95. PubMed ID: 27235787
[TBL] [Abstract][Full Text] [Related]
6. Distinct Electrogram Features and Ventricular Arrhythmia Induction Modes Between Repolarization and Conduction Heterogeneities.
Renard E; Surget E; Walton RD; Michel C; Benoist D; Dubes V; Guillot B; Martinez ME; Hocini M; Haïssaguerre M; Bernus O
JACC Clin Electrophysiol; 2024 Apr; ():. PubMed ID: 38661605
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of antiarrhythmic effects of flecainide in catecholaminergic polymorphic ventricular tachycardia.
Watanabe H; Steele DS; Knollmann BC
Circ Res; 2011 Sep; 109(6):712-3. PubMed ID: 21885838
[No Abstract] [Full Text] [Related]
8. Interventricular Differences in Action Potential Duration Restitution Contribute to Dissimilar Ventricular Rhythms in
Handa BS; Lawal S; Wright IJ; Li X; Cabello-García J; Mansfield C; Chowdhury RA; Peters NS; Ng FS
Front Cardiovasc Med; 2019; 6():34. PubMed ID: 31001543
[No Abstract] [Full Text] [Related]
9. Dominant rule of community effect in synchronized beating behavior of cardiomyocyte networks.
Yasuda K
Biophys Rev; 2020 Apr; 12(2):481-501. PubMed ID: 32367300
[TBL] [Abstract][Full Text] [Related]
10. On-chip spatiotemporal electrophysiological analysis of human stem cell derived cardiomyocytes enables quantitative assessment of proarrhythmia in drug development.
Asahi Y; Hamada T; Hattori A; Matsuura K; Odaka M; Nomura F; Kaneko T; Abe Y; Takasuna K; Sanbuissho A; Yasuda K
Sci Rep; 2018 Sep; 8(1):14536. PubMed ID: 30266924
[TBL] [Abstract][Full Text] [Related]
11. Effects of Na+ channel blockers on the restitution of refractory period, conduction time, and excitation wavelength in perfused guinea-pig heart.
Osadchii OE
PLoS One; 2017; 12(2):e0172683. PubMed ID: 28231318
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Index of Cardio-Electrophysiological Balance (iCEB) as a New Biomarker for the Identification of Patients at Increased Arrhythmic Risk.
Robyns T; Lu HR; Gallacher DJ; Garweg C; Ector J; Willems R; Janssens S; Nuyens D
Ann Noninvasive Electrocardiol; 2016 May; 21(3):294-304. PubMed ID: 26305685
[TBL] [Abstract][Full Text] [Related]
13. Effects of Na+ channel blockers on extrasystolic stimulation-evoked changes in ventricular conduction and repolarization.
Osadchii OE
J Cardiovasc Pharmacol; 2014 Mar; 63(3):240-51. PubMed ID: 24220314
[TBL] [Abstract][Full Text] [Related]
14. Procainamide and lidocaine produce dissimilar changes in ventricular repolarization and arrhythmogenicity in guinea-pig.
Osadchii OE
Fundam Clin Pharmacol; 2014 Aug; 28(4):382-93. PubMed ID: 23952942
[TBL] [Abstract][Full Text] [Related]
15. Quinidine elicits proarrhythmic changes in ventricular repolarization and refractoriness in guinea-pig.
Osadchii OE
Can J Physiol Pharmacol; 2013 Apr; 91(4):306-15. PubMed ID: 23627842
[TBL] [Abstract][Full Text] [Related]
16. Flecainide attenuates rate adaptation of ventricular repolarization in guinea-pig heart.
Osadchii OE
Scand Cardiovasc J; 2016; 50(1):28-35. PubMed ID: 26402340
[TBL] [Abstract][Full Text] [Related]
17. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
Kreeger RW; Hammill SC
Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
